Form D · Hedge Fund

Parallax Biomedical Fund, L.P.

San Francisco, CA · CIK 0001267820

Offering snapshot reported Feb 26, 2013 · SEC filing

Reported sold: $8.55M
Investors reported: 36
Minimum accepted: $250K
First sale: Jun 3, 2003

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$4,270,000 → $8,546,000
Reported investors19 → 36

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Feb 26, 2013	Amendment	$8,546,000	$4,276,000vs Feb 24, 2012	36	SEC filing
Feb 24, 2012	Amendment	$4,270,000	No comparison	19	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06, 3C, 3C.1
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-59667

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
David Arnold Spiller	4347237

Source: Form D, filed Feb 26, 2013. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Marc Pentopoulos	Director, Executive, Promoter
Kellie Lynn Seringer	Director, Executive, Promoter
David Arnold Spiller	Executive, Promoter
None Symmetry Capital Management, Llc	Director, Executive, Promoter

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

2169 Folsom Street Suite 305
San Francisco, CA, 94110